LXRs regulate features of age-related macular degeneration and may be a potential therapeutic target

Autor: Ebraheim N. Ismail, Rajendra S. Apte, Steven Nusinowitz, James T. Handa, Jeffrey W. Ruberti, Peter Tontonoz, Faryan Tayyari, Goldis Malek, Michael E. Boulton, Mayur Choudhary, Pei-Li Yao, Roxana A. Radu
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Aging
genetic structures
Retinal Pigment Epithelium
Neurodegenerative
Inbred C57BL
Mouse models
Eye
Mice
Macular Degeneration
0302 clinical medicine
80 and over
2.1 Biological and endogenous factors
Medicine
Aetiology
Liver X Receptors
Aged
80 and over

Mice
Knockout

General Medicine
Middle Aged
Phenotype
medicine.anatomical_structure
030220 oncology & carcinogenesis
Female
lipids (amino acids
peptides
and proteins)

medicine.symptom
Research Article
Adult
Adolescent
Knockout
Inflammation
Therapeutics
Retina
Proinflammatory cytokine
Young Adult
03 medical and health sciences
Downregulation and upregulation
Animals
Humans
Retinopathy
Liver X receptor
Eye Disease and Disorders of Vision
Aged
Retinal pigment epithelium
Animal
business.industry
Neurosciences
Endothelial Cells
Lipid metabolism
Macular degeneration
medicine.disease
eye diseases
Mice
Inbred C57BL

Disease Models
Animal

Ophthalmology
030104 developmental biology
Nuclear receptor
Disease Models
Cancer research
sense organs
Transcriptome
Digestive Diseases
business
Genome-Wide Association Study
Zdroj: JCI insight, vol 5, iss 1
ISSN: 2379-3708
DOI: 10.1172/jci.insight.131928
Popis: Effective treatments and animal models for the most prevalent neurodegenerative form of blindness in elderly people, called age-related macular degeneration (AMD), are lacking. Genome-wide association studies have identified lipid metabolism and inflammation as AMD-associated pathogenic pathways. Given liver X receptors (LXRs), encoded by the nuclear receptor subfamily 1 group H members 2 and 3 (NR1H3 and NR1H2), are master regulators of these pathways, herein we investigated the role of LXR in human and mouse eyes as a function of age and disease and tested the therapeutic potential of targeting LXR. We identified immunopositive LXR fragments in human extracellular early dry AMD lesions and a decrease in LXR expression within the retinal pigment epithelium (RPE) as a function of age. Aged mice lacking LXR presented with isoform-dependent ocular pathologies. Specifically, loss of the Nr1h3 isoform resulted in pathobiologies aligned with AMD, supported by compromised visual function, accumulation of native and oxidized lipids in the outer retina, and upregulation of ocular inflammatory cytokines, while absence of Nr1h2 was associated with ocular lipoidal degeneration. LXR activation not only ameliorated lipid accumulation and oxidant-induced injury in RPE cells but also decreased ocular inflammatory markers and lipid deposition in a mouse model, thereby providing translational support for pursuing LXR-active pharmaceuticals as potential therapies for dry AMD.
Databáze: OpenAIRE